MAPK1 and neoplasm: In order to test whether resistance to these agents can be overcome by ERK inhibition, several in vitro studies were performed and treatment of tumor cell lines resistant to RAF and/or MEK inhibitors showed sensitivity to ERK inhibitors (SCH772984 or VTX-11e) [21,25].